Skip to content
10-Q

Quarterly Report

Impact BioMedical, INC. IBO

0001493152-26-022512

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 107.82M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$464K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$682K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $20K
Cash And Equivalents Q1 2026 · Dec 31, 2025 $3K
Stockholders Equity Q1 2026 · Mar 31, 2026 $11.46M
Stockholders Equity Q1 2026 · Dec 31, 2025 $12.31M
Current Liabilities Q1 2026 · Mar 31, 2026 $1.69M
Current Liabilities Q1 2026 · Dec 31, 2025 $1.16M
Total Liabilities Q1 2026 · Mar 31, 2026 $2.38M
Total Liabilities Q1 2026 · Dec 31, 2025 $1.85M
Current Assets Q1 2026 · Mar 31, 2026 $377K
Current Assets Q1 2026 · Dec 31, 2025 $411K
Total Assets Q1 2026 · Mar 31, 2026 $17.09M
Total Assets Q1 2026 · Dec 31, 2025 $17.41M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.02
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.11
Eps Basic Q1 2026 · Mar 31, 2026 −$0.02
Eps Basic Q1 2026 · Mar 31, 2025 −$0.11
Sga Expense Q1 2026 · Mar 31, 2026 $1.62M
Sga Expense Q1 2026 · Mar 31, 2025 $248K
Rd Expense Q1 2026 · Mar 31, 2026 $46K
Rd Expense Q1 2026 · Mar 31, 2025 $103K
Net Income Q1 2026 · Mar 31, 2026 −$2.29M
Net Income Q1 2026 · Mar 31, 2025 −$1.27M
Operating Income Q1 2026 · Mar 31, 2026 −$2.29M
Operating Income Q1 2026 · Mar 31, 2025 −$1.01M
Revenue Q1 2026 · Mar 31, 2026 $7K